BIOMAT Database Logo BIOMAT Database Logo

[Myasthenia gravis with myocarditis and sudden death]. 1987

H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug

UI MeSH Term Description Entries
D008297 Male Males
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D003645 Death, Sudden The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions. Sudden Death
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013945 Thymoma A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed) Carcinoma, Thymic,Carcinomas, Thymic,Thymic Carcinoma,Thymic Carcinomas,Thymomas
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus

Related Publications

H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Myocarditis in myasthenia gravis.
April 2016, International journal of cardiology,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Thymoma-Associated Myasthenia Gravis With Myocarditis.
July 2023, Cureus,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
MYOCARDITIS IN MYASTHENIA GRAVIS WITH THYMOMA.
October 1963, Irish journal of medical science,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis.
January 2017, Case reports in oncology,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Familial infantile myasthenia gravis: a preventable cause of sudden death.
February 1985, Southern medical journal,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
A systematic review of myasthenia gravis complicated with myocarditis.
August 2021, Brain and behavior,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis.
November 2023, The Canadian journal of cardiology,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis.
September 2021, Cureus,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan.
September 2017, Neurology,
H Hofstad, and N E Gilhus, and J A Aarli, and H Gjengstø, and S J Mørk, and J E Varhaug
Familial infantile myasthenia gravis: a cause of sudden death in young children.
September 1975, The Journal of pediatrics,
Copied contents to your clipboard!